Skip to Main Content
TRC_PLC_New
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • NetCE All Access: Behaviorial Health
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Natural Medicines Resources
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • New Drugs
    • Do Not Crush List
    • Stepwise Treatment of Type 2 Diabetes
    • Contraceptives
    • Antidepressants
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

NatMed Pro, the largest natural medicines database, just got a major upgrade! With faster performance, a redesigned interface, and improved navigation, it's easier than ever to find the evidence-based answer you need. Explore Now
  1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Diabetes
  5. Treatment
  6. Sulfonylureas

Sulfonylureas

  • Diabetes (801)
    • Blood Glucose Meters (4)
    • Complications (179)
    • Diabetes in Pregnancy (14)
    • Diabetes Meds (72)
    • Drug-Induced Hypo/Hyperglycemia (134)
    • Monitoring (128)
    • Natural Medicines/Supplements (14)
    • Prevention (56)
    • Treatment (343)
      • Alpha-Glucosidase Inhibitors (28)
      • Amylin Agonist (14)
      • Bromocriptine (7)
      • Combination Products (19)
      • Gliptins (77)
      • Glitazones (115)
      • GLP-1 (42)
      • Incretin Enhancers/Mimetics (68)
      • Insulin (174)
      • Meglitinides (41)
      • Metformin (156)
      • SGLT2 Inhibitors (84)
      • Sulfonylureas (110)
      • Treatment of Pediatric Metabolic Syndrome (10)
  • Endocrinology (13)
  • Hyperglycemia (29)
  • Hypoglycemia (29)
  • Other (28)
  • Prediabetes (5)
  • Resources (222)
  • Thyroid Disorders (57)
106 - 110 of 110 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
Guideline: Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity June 2008
Guideline: Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents June 2008
Article: treating metabolic syndrome in kids June 2008
Article: misuse of the Beers criteria to determine drug therapy in the elderly September 2007
Guideline: Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach (2012) November 2006
  • « Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • About Us
  • Our Mission
  • Our Team
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.



© Therapeutic Research Center. All Rights Reserved